Litcius/Paper detail

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

Yezi Zhu, Susan L. Dalrymple, Ilsa M. Coleman, Shun Zheng, Jianfeng Xu, Jody E. Hooper, Emmanuel S. Antonarakis, Angelo M. De Marzo, Alan K. Meeker, Peter S. Nelson, William B. Isaacs, Samuel R. Denmeade, Jun Luo, W. Nathaniel Brennen, John T. Isaacs

2020Oncogene105 citationsDOIOpen Access PDF

Topics & Concepts

EnzalutamideAndrogen receptorBiologyProstate cancerCancer researchLNCaPCancerInternal medicineEndocrinologyGeneticsMedicineProstate Cancer Treatment and ResearchHormonal and reproductive studiesSexual Differentiation and Disorders
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors | Litcius